-Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump SAN DIEGO, CA / ACCESS Newswire / September 15, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or ...
"The Pivot submission is an exciting milestone in our mission to deliver a differentiated tubeless patch pump experience to those who want a simple pump to manage the treatment of diabetes," commented ...
Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System
Pivot Controller Line Validated: Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch. Pivot will be First Two-Part Tubeless Patch Pump: ...
- Will introduce first level of its gamified training application developed by Level Ex, developers of the Level One diabetes-management game SAN DIEGO, CA / ACCESS Newswire / August 8, 2025 / Modular ...
SAN DIEGO - Modular Medical, Inc. (NASDAQ:MODD) announced Monday it has successfully validated its Pivot controller manufacturing line for human-use production, a key milestone ahead of the company’s ...
The MarketWatch News Department was not involved in the creation of this content. -Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump SAN DIEGO, CA / ACCESS Newswire ...
Submission delayed by U.S. government shutdown; initial FDA questions expected during Q4 2025 "The Pivot submission is an exciting milestone in our mission to deliver a differentiated tubeless patch ...
SAN DIEGO, CA / ACCESS Newswire / September 15, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback